STAT1 and infection: No significant differences in survival were observed between mice treated with high (Fig. 5A left panel) and low (Fig. 5A, right panel) amounts of dox., i.e. lower levels of STAT1 prior to infection do not impair STAT1-mediated antiviral activity and survival against VSV.